IDiyas

For the Inventor, By the Inventor

Blue Bell, PA, United States of America

Jason M Elliott

USPTO Granted Patents = 13

Average Co-Inventor Count = 5.6

ph-index = 8

Forward Citations = 265(Granted Patents)


Location History:

  • Harleysville, PA (US) (1995)
  • Kent, GB (1995)
  • Blue Bell, PA (US) (1991 - 1997)
  • London, GB (1997)

Company Filing History:

goldMedal13 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1991-1997

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5698566 - Nitrogen-containing spirocycles (1997-12-16),
2. 5679672 - Benzodiazepines (1997-10-21),
3. 5633247 - Nitrogen-containing spirocycles (1997-05-27),
4. 5595990 - Antiarrhythmic benzodiazepines (1997-01-21),
5. 5438055 - Antiarrhythmic benzodiazepines (1995-08-01),
6. 5428157 - 3-acylaminobenzodiazepines (1995-06-27),
7. 5426185 - Antiarrhythmic benzodiazepines (1995-06-20),
8. 5382587 - Spirocycles (1995-01-17),
9. 5215989 - Nitrogen-containing heterocyclic compounds as class III antiarrhythmic (1993-06-01),
10. 5206240 - Nitrogen-containing spirocycles (1993-04-27),
11. 5112824 - Benzofuran compounds as class III antiarrhythmic agents (1992-05-12),
12. 5032604 - Class III antiarrhythmic agents (1991-07-16),
13. 5032598 - Nitrogens containing heterocyclic compounds as class III antiarrhythmic (1991-07-16),

Title: The Innovative Journey of Jason M. Elliott

Introduction

Jason M. Elliott is a prominent inventor based in Blue Bell, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, holding a total of 13 patents. His work primarily focuses on the development of novel compounds that have the potential to impact various therapeutic areas.

Latest Patents

Among his latest patents are innovations in nitrogen-containing spirocycles and benzodiazepines. These compounds are crucial in the development of new medications that can address various health issues. His research and inventions continue to push the boundaries of pharmaceutical science.

Career Highlights

Jason is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development efforts. His extensive experience and expertise have made him a valuable asset to the company.

Collaborations

Throughout his career, Jason has worked alongside notable colleagues such as John J. Baldwin and David A. Claremon. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical products.

Conclusion

Jason M. Elliott's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to innovation. His work continues to influence the industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…